. . . . . . . . "Loss of enzymatic activity. Increases the steady-state level of MDM2 and MDM4 that leads to attenuation of MDM2-mediated degradation of p53/TP53 and MDM4. Increases the level of p53/TP53 and MDM4 ubiquitin conjugates." . "340"^^ . . "340"^^ . . "Mutagenesis site occurs in NX_O75604-4 at amino acids 340 - 340." . . . . . "neXtProt gold" . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "2" . . .